A researcher conducts an experiment with patients in a clinic. Group A is randomized to receive the new experimental therapy. Group B is randomized to receive treatment as usual, or TAU (the normal course of therapy for patients in the clinic).
The TAU group is
a) the control group
b) an extraneous variable.
c) the dependent variable.
d) the experimental group.
Question 2
Imagine you have formed a research question, conducted the literature review, integrated your findings, and formed a hypothesis. Now that you are submitting your IRB application, you should expect the IRB to
a) ensure your proposed study will treat participants ethically
b) critique the scientific merits of your study.
c) critique your hypothesis based upon your literature review.
d) ensure that you are able to collect a representative sample of participants.
A hypothesis that suggests an explanation of the function of the gene that is defective in patients
Aerial and close-up views of a large biodiversity experiment in Cedar Creek, Minnesota. Each of the
The Redi experiment.
Nurse's hand over patients abdomen
Group Studying
Principal component analysis of blood plasma metabolites in chronic myeloid leukemia (CML) patients